Pharma payment disclosures ‘a breach of privacy’

A Brisbane endocrinologist has labelled Medicines Australia’s new code of conduct requiring public disclosure of pharmaceutical company payments to doctors “a breach of privacy”.

Associate Professor Michael d’Emden, director of endocrinology at Queensland Health, says disclosures should be restricted to a “professional level”, such as reporting conflict of interests in submissions to government bodies.